Predictive role of neutrophil‐percentage‐to‐albumin, neutrophil‐to‐lymphocyte and eosinophil‐to‐lymphocyte ratios for mortality in patients with COPD: Evidence from NHANES 2011–2018
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Background and Objective: This study evaluated the predictive roles of hematologic inflammatory biomarkers including neutrophil‐percentage‐to‐albumin ratio (NPAR), neutrophil‐to‐lymphocyte ratio (NLR) and eosinophil‐to‐lymphocyte ratio (ELR) for mortality in community‐dwelling individuals with chronic obstructive pulmonary disease (COPD). Methods: This longitudinal study extracted data of adults 40–79 years who had physician‐diagnosed COPD from the United States (US) National Health and Nutrition Examination Survey (NHANES) 1999–2018. Cox regressions determined the associations between NPAR, NLR, ELR and their components, with all‐cause mortality, cardiovascular disease (CVD) mortality and mortality from chronic lower respiratory disease (CLRD). Receiver operating characteristic (ROC) curve analysis estimated the predictive performances of these biomarkers for 5‐year all‐cause mortality. Results: Data of 1158 subjects were analysed. After adjustment, higher NPAR was significantly associated with increased all‐cause and CVD mortality, and mortality from CLRD (adjusted hazard ratio [aHR] = 1.14, 1.15 and 1.16). Higher NLR was associated with an increased all‐cause and CVD mortality (aHR = 1.16 and 1.29). Higher neutrophil was associated with increased all‐cause mortality and mortality from CLRD (aHR = 1.13 and 1.34). Albumin was associated with decreased all‐cause and CVD mortality (aHR = 0.91 and 0.86). ELR, eosinophil or lymphocyte was not significantly associated with either mortality outcomes. Adjusted AUC of NPAR and NLR in predicting 5‐year all‐cause mortality were 0.808 (95% CI: 0.722–0.845) and 0.799 (95% CI: 0.763–0.835), respectively. Conclusion: In community‐dwelling US adults with COPD, increased NPAR and NLR are associated with mortality risks. NPAR outperforms the other hematologic inflammatory biomarkers in predicting 5‐year all‐cause mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,830
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971 · cited 1×
“6,7 COPD is a heterogeneous syndrome with complex pathophysiological mechanisms and different clinical phenotypes, which together may negatively affect accurate diagnosis and treatment.”
BackgroundPoints of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738 · cited 1×
“5 Absolute counts and ratios of key immune-related cell populations in peripheral blood adequately reflect chronic inflammatory conditions.”
BackgroundNeutrophils, from Marrow to Microbes
Borregaard, N. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.011 · Cited by 1,573 · cited 1×
“6,7 COPD is a heterogeneous syndrome with complex pathophysiological mechanisms and different clinical phenotypes, which together may negatively affect accurate diagnosis and treatment.”
BackgroundChronic obstructive pulmonary disease
Christenson, S. A., Smith, B. M., Bafadhel, M., & Putcha, N. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00470-6 · Cited by 1,219 · cited 1×
“3 As the prevalence has increased during population aging, COPD has become the third most common global cause of morbidity and mortality.”
BackgroundNational health and nutrition examination survey: plan and operations, 1999-2010.
Zipf, G., Chiappa, M. M., Porter, K. S., Ostchega, Y., Lewis, B. G., & Dostal, J. (2013) · PubMed · Cited by 1,182
Role of inflammatory cells in airway remodeling in COPD
Wang, Y., Xu, J., Meng, Y., Adcock, I. M., & Yao, X. (2018) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s176122 · Cited by 373 · cited 2×
“23,24 Because prognostic stratification of COPD patients is difficult and wide variability exists between individuals in the disease process, no single marker can accurately stratify the development and progression of inflammatory disease in COPD patients.”
BackgroundInflammatory endotypes in COPD
Barnes, P. J. (2019) · Allergy · doi:10.1111/all.13760 · Cited by 313 · cited 2×
“23,24 Because prognostic stratification of COPD patients is difficult and wide variability exists between individuals in the disease process, no single marker can accurately stratify the development and progression of inflammatory disease in COPD patients.”
BackgroundSchnell, K., Weiss, C. O., Lee, T., Krishnan, J. A., Leff, B., Wolff, J. L., & Boyd, C. (2012) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-12-26 · Cited by 274
Neutrophil-to-Lymphocyte Ratio in Chronic Obstructive Pulmonary Disease: A Retrospective Study
Günay, E., Sarınç Ulaşlı, S., Akar, O., Ahsen, A., Günay, S., Koyuncu, T., & Ünlü, M. (2014) · Inflammation · doi:10.1007/s10753-013-9749-1 · Cited by 208 · cited 1×
“Gunay et al. 11 first identified NLR as a rapid and easily measurable biomarker of inflammation severity in COPD patients.”
BackgroundGong, Y., Li, D., Cheng, B., Ying, B., & Wang, B. (2020) · Epidemiology and Infection · doi:10.1017/s0950268820000771 · Cited by 174 · cited 1×
“31 Another study examined the effects of NPAR on the prognosis of patients in the coronary care unit, suggesting that it was an independent risk factor for in-hospital mortality in this patient population.”
BackgroundGhobadi, H., Mohammadshahi, J., Javaheri, N., Fouladi, N., Mirzazadeh, Y., & Aslani, M. R. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.916453 · Cited by 147 · cited 1×
“33 The authors concluded that WBC and neutrophil count were reliable predictors of in-hospital mortality in both elderly and non-elderly patients admitted for COVID-19.”
BackgroundChronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer
Szalontai, K., Gémes, N., Furák, J., Varga, T., Neuperger, P., Balog, J. Á., Puskás, L. G., & Szebeni, G. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132889 · Cited by 141
Zinellu, A., Zinellu, E., Mangoni, A. A., Pau, M. C., Carru, C., Pirina, P., & Fois, A. G. (2022) · European Respiratory Review · doi:10.1183/16000617.0095-2022 · Cited by 138 · cited 1×
“28 That narrative review also demonstrated that NLR is a simple and inexpensive marker of inflammation that has been increasingly studied in several disease states, including COPD, and appears to be a promising predictor of mortality in COPD patients.”
BackgroundCan we predict the prognosis of COPD with a routine blood test?
Xiong, W. G., Xu, M., Zhao, Y., Wu, X., Pudasaini, B., & Liu, J. (2017) · International Journal of COPD · doi:10.2147/copd.s124041 · Cited by 109 · cited 1×
“12,13 In addition, neutrophil-percentage-to-albumin ratio (NPAR), a composite biomarker of neutrophils and albumin, calculated by dividing the neutrophil percentage numerator serum albumin concentration, is another cost-effective and readily available biomarker.”
BackgroundSun, T., Shen, H., Guo, Q., Yang, J., Zhai, G., Zhang, J., Zhang, B., Ding, Y., Cai, C., & Zhou, Y. (2020) · BioMed Research International · doi:10.1155/2020/8137576 · Cited by 98 · cited 1×
“32 A very recent study by Ghobadi et al. evaluated the role of leukocytes and systemic inflammation indexes including admission NLR, PLR, monocyte-lymphocyte ratio (MLR), neutrophil/lymphocyte * platelet ratio (NLPR), derived neutrophil/lymphocyte ratio (dNLR), aggregate index of systemic…”
BackgroundTaylan, M., Demir, M., Kaya, H., Şen, H. S., Abakay, Ö., Çarkanat, A. İ., Abakay, A., Tanrıkulu, A. Ç., & Sezgı, C. (2015) · The Clinical Respiratory Journal · doi:10.1111/crj.12336 · Cited by 93 · cited 1×
“12,13 In addition, neutrophil-percentage-to-albumin ratio (NPAR), a composite biomarker of neutrophils and albumin, calculated by dividing the neutrophil percentage numerator serum albumin concentration, is another cost-effective and readily available biomarker.”
BackgroundHosseninia, S., Ghobadi, H., Garjani, K., Hosseini, S. A. H., & Aslani, M. R. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02397-5 · Cited by 78
Qiu, Y., Wang, Y., Shen, N., Wang, Q., Chai, L., Liu, J. H., Chen, Y., & Li, M. (2022) · International Journal of COPD · doi:10.2147/copd.s371765 · Cited by 55 · cited 2×
“29 In the present study, we confirmed that NPAR and NLR are both predictive of COPD mortality, and the performance of NPAR is slightly better than that of NLR. NPAR is a relatively new inflammatory marker, and few studies have explored its prognostic value.”
BackgroundGao, X., Coull, B. A., Lin, X., Vokonas, P., Sparrow, D., Hou, L., DeMeo, D. L., Litonjua, A. A., Schwartz, J. D., & Baccarelli, A. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.10350 · Cited by 52 · cited 2×
“26 That study demonstrated that NLR is a clinically relevant biomarker associated with impaired lung function and high risk of COPD, illustrating associations with DNA methylation profiles.”
BackgroundBarouchos, N., Papazafiropoulou, A. K., Iacovidou, N. M., Vrachnis, N., Barouchos, N., Armeniakou, E., Dionyssopoulou, V., Mathioudakis, A. G., Eleni, C., Koltsida, S., et al. (2015) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.992944 · Cited by 47 · cited 1×
“9,10 Recently, neutrophil-to-lymphocyte ratio (NLR) in peripheral blood has attracted more attention as a biomarker of inflammation.”
BackgroundLu, F., Chen, R., Li, N., Sun, X., Zhou, M., Li, Q., & Guo, Y. (2021) · International Journal of COPD · doi:10.2147/copd.s290422 · Cited by 46 · cited 1×
“27 A previous narrative review discussed the relationship between NLR and the PLR on admission and several clinical endpoints in COPD.”
BackgroundHolub, K., & Biete, A. (2018) · BMC Cancer · doi:10.1186/s12885-018-5131-x · Cited by 46
Relative lymphocyte count as an indicator of 3-year mortality in elderly people with severe COPD
Acanfora, D., Scicchitano, P., Carone, M., Acanfora, C., Piscosquito, G., Maestri, R., Zito, A., Dentamaro, I., Longobardi, M., Casucci, G., et al. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0685-6 · Cited by 45 · cited 1×
“25 Those authors emphasized the association between lower relative lymphocyte counts and higher 3-year mortality in older adult patients with severe COPD.”
BackgroundKaradeniz, G., Aktoğu, S., Erer, O. F., Kır, S. B., Doruk, S., Demir, M., & Sonat, K. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0046 · Cited by 38 · cited 1×
“9,10 Recently, neutrophil-to-lymphocyte ratio (NLR) in peripheral blood has attracted more attention as a biomarker of inflammation.”
BackgroundDu, X., Wei, X., Ma, L., Liu, X., Guo, H., Liu, Y., & Zhang, J. (2022) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002470 · Cited by 36 · cited 1×
“30 However, NPAR has been shown to correlate with prognosis in various other diseases.”
BackgroundEosinopenia and neutrophil-to-lymphocyte count ratio as prognostic factors in exacerbation of COPD
Karauda, T., Kornicki, K., Jarri, A. I., Antczak, A. J., Miłkowska-Dymanowska, J., Piotrowski, W. J., Majewski, S., Górski, P., & Białas, A. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-84439-8 · Cited by 32 · cited 1×
“16 Studies have demonstrated an association between ELR and adverse events in patients with malignancy and heart failure.”
BackgroundIbrahimou, B., Azim, S. I., & Sun, N. (2019) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2019.101805 · Cited by 31
Jurevičienė, E., Burneikaitė, G., Dambrauskas, L., Kasiulevičius, V., Kazėnaitė, E., Navickas, R., Puronaitė, R., Smailytė, G., Visockienė, Ž., & Danila, E. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19020970 · Cited by 22
Vural, A., & Aydın, E. (2022) · Medicina · doi:10.3390/medicina58101455 · Cited by 15 · cited 1×
“17,18 However, to the best of our knowledge, no study in the medical literature has compared the prognostic significance of NPAR, NLR and ELR on the long-term mortality outcomes in patients with COPD.”
Background
Metadata
- Authors
- Lan, C., Su, W., Yang, M., Chen, S., & Wu, Y.
- Venue
- Respirology
- Publisher
- Wiley
- Published
- 2023-09
- Volume
- 28
- Issue
- 12
- Pages
- 1136-1146
- ISSN
- 1323-7799 (ISSN-L)
- 1440-1843
- OpenAlex
- W4386347287
- Cited by
- 165
- References
- 30
- FWCI
- 17.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.